FGFR3 signaling and function in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) accounts for 16% of breast cancers and represents an aggressive subtype that lacks targeted therapeutic options. In this study, mass spectrometry (MS)-based tyrosine phosphorylation profiling identified aberrant FGFR3 activation in a subset of TNBC ce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Commun Signal
Autors principals: Chew, Nicole J., Nguyen, Elizabeth V., Su, Shih-Ping, Novy, Karel, Chan, Howard C., Nguyen, Lan K., Luu, Jennii, Simpson, Kaylene J., Lee, Rachel S., Daly, Roger J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986078/
https://ncbi.nlm.nih.gov/pubmed/31987043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-019-0486-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars